Follicle Stimulating Hormone

Follicle-Stimulating Hormone (FSH) is a key hormone produced by the anterior pituitary gland that regulates ovarian function, egg maturation, and estrogen production. It works hand-in-hand with luteinizing hormone (LH) to coordinate the menstrual cycle and support fertility. FSH stimulates the ovarian follicles that grow and release an egg during ovulation, while also helping regulate estrogen levels. Because FSH is tightly linked to ovarian and pituitary function, it’s one of the most important markers for understanding reproductive health, menstrual regularity, and hormonal balance.

FSH levels normally change across different phases of the menstrual cycle and during perimenopause. The reference ranges below help interpret your FSH result based on which phase of your cycle your blood test was taken.

Follicle-Stimulating Hormone reference ranges in IU/L:

Follicular phase: 1 - 10

Mid-cycle (ovulatory phase): >10

Luteal phase: 1 - 10

Perimenopausal: >20

FSH provides valuable insight into how well the ovaries are responding to signals from the brain. In the first half of the menstrual cycle, it drives follicle growth and oestrogen production. When oestrogen levels are adequate, the brain reduces FSH output through a negative feedback loop, maintaining hormonal balance. However, when the ovaries begin to lose responsiveness — such as during perimenopause or ovarian insufficiency — the brain compensates by producing more FSH. Elevated FSH is therefore a hallmark of declining ovarian reserve or menopause. Conversely, low FSH can point to hypothalamic or pituitary dysfunction, often caused by chronic stress, under-nutrition, or over-exercise.

Beyond reproduction, FSH also influences bone density, mood stability, and cardiovascular health through its relationship with oestrogen. Understanding FSH patterns helps identify early hormonal changes that can impact fertility, metabolic health, and long-term wellbeing.

FSH levels naturally rise and fall in response to reproductive, metabolic, and lifestyle factors.

• Menstrual Cycle: FSH peaks in the early follicular phase (days 2–4) to stimulate egg development, then surges again before ovulation. Levels drop once ovulation occurs and oestrogen rises.

• Age and Menopause: As ovarian follicles diminish with age, oestrogen production falls and FSH rises. Perimenopause is marked by irregular FSH spikes, while postmenopause shows persistently high levels.

• Stress and Lifestyle: Chronic stress, illness, or under-eating can suppress hypothalamic signalling, reducing FSH output. On the other hand, smoking and aging accelerate ovarian decline, increasing FSH.

• Body Weight and Exercise: Being underweight or overweight disrupts hormonal signalling. Overtraining and caloric restriction can lower FSH, while excess body fat may contribute to estrogen dominance and irregular cycles.

FSH levels can become imbalanced for several reasons. High FSH may indicate menopause, primary ovarian insufficiency, or reduced ovarian reserve. It can also occur with certain pituitary or adrenal disorders. Low FSH is often seen in hypothalamic amenorrhea caused by excessive stress, under-nutrition, or over-exercise. Other causes include pituitary disorders, thyroid dysfunction, or the use of hormonal contraceptives that suppress natural FSH production.

Childhood and Puberty
Before puberty, FSH remains low. As puberty begins, rising FSH stimulates oestrogen production, breast development, and the start of menstrual cycles. These changes mark the maturation of the reproductive system and the onset of fertility.

Reproductive Years
During the reproductive years, FSH fluctuates in a cyclical rhythm to regulate ovulation and oestrogen synthesis. Optimal levels (2.5–10.2 mIU/mL when tested on days 2–4) indicate healthy ovarian signalling. Low FSH may signal pituitary suppression or hypothalamic amenorrhea, often due to stress or inadequate energy intake. Elevated FSH, however, can suggest early ovarian aging or primary ovarian insufficiency (POI). In PCOS, FSH may appear normal but is often lower relative to LH, creating a high LH:FSH ratio that contributes to irregular ovulation and hormonal imbalance.

Perimenopause
As women approach menopause, FSH levels become erratic. The ovaries produce less oestrogen, leading the pituitary gland to increase FSH output in an attempt to stimulate them. This results in irregular cycles, mood swings, night sweats, and other transitional symptoms. FSH testing during this time helps track the shift toward menopause, though it should always be interpreted alongside oestradiol and symptom history.

Postmenopause
After menopause, oestrogen production from the ovaries declines sharply and FSH remains persistently high (typically 23–116 mIU/mL). This is a normal finding and reflects the body’s adaptation to the post-reproductive phase. However, unusually low FSH in a postmenopausal woman may point to pituitary dysfunction or an oestrogen-secreting tumour. High FSH combined with very low oestrogen can also accelerate bone loss, vaginal dryness, and reduced libido — all signs of oestrogen deficiency that may benefit from clinical support.

FSH levels are sensitive to daily habits and environmental stressors.

• Smoking is associated with higher FSH levels and faster ovarian aging.

• Diets lacking healthy fats and essential nutrients can impair hormone synthesis.

• Chronic stress and sleep deprivation suppress pituitary signaling, while consistent movement and balanced nutrition support hormonal equilibrium.

• Achieving and maintaining a healthy weight — not too low, not too high — is key to maintaining optimal FSH and menstrual function.

1. Padmanabhan, V., & Cardoso, R. C. (2020). Neuroendocrine, autocrine, and paracrine control of follicle-stimulating hormone secretion. Molecular and Cellular Endocrinology, 500, 110632. https://doi.org/10.1016/j.mce.2019.110632

2. Recchia, K., Jorge, A. S., & Pessôa, L. V. F. (2021). Actions and roles of FSH in germinative cells. International Journal of Molecular Sciences, 22(18), 10110. https://doi.org/10.3390/ijms221810110

3. Sherman, B. M., & Korenman, S. G. (1975). Hormonal characteristics of the human menstrual cycle throughout reproductive life. The Journal of Clinical Investigation, 55(4), 699–706. https://doi.org/10.1172/JCI107979

4. Sowers, M. R., Zheng, H., & McConnell, D. (2008). Follicle stimulating hormone and its rate of change in defining menopause transition stages. The Journal of Clinical Endocrinology & Metabolism, 93(10), 3958–3964. https://doi.org/10.1210/jc.2008-0482

5. Lambalk, C. B., & de Koning, C. H. (1998). Interpretation of elevated FSH in the regular menstrual cycle. Maturitas, 30(2), 215–220. https://doi.org/10.1016/s0378-5122(98)00076-0

6. Kim, C., Randolph, J. F., & Golden, S. H. (2015). Weight loss increases follicle-stimulating hormone in overweight postmenopausal women. Obesity (Silver Spring, Md.), 23(1), 228–233. https://doi.org/10.1002/oby.20917